Free Trial
NYSE:USNA

USANA Health Sciences (USNA) Stock Price, News & Analysis

USANA Health Sciences logo
$27.41 +0.14 (+0.52%)
Closing price 10/2/2025 03:59 PM Eastern
Extended Trading
$27.44 +0.03 (+0.10%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About USANA Health Sciences Stock (NYSE:USNA)

Advanced

Key Stats

Today's Range
$26.88
$27.45
50-Day Range
$27.38
$32.20
52-Week Range
$23.10
$41.83
Volume
106,121 shs
Average Volume
147,349 shs
Market Capitalization
$500.82 million
P/E Ratio
15.23
Dividend Yield
N/A
Price Target
$36.00
Consensus Rating
Hold

Company Overview

USANA Health Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
91st Percentile Overall Score

USNA MarketRank™: 

USANA Health Sciences scored higher than 91% of companies evaluated by MarketBeat, and ranked 82nd out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    USANA Health Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    USANA Health Sciences has a consensus price target of $36.00, representing about 31.3% upside from its current price of $27.41.

  • Amount of Analyst Coverage

    USANA Health Sciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about USANA Health Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for USANA Health Sciences are expected to grow by 17.96% in the coming year, from $2.45 to $2.89 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of USANA Health Sciences is 15.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 281.79.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of USANA Health Sciences is 15.23, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.39.

  • Price to Earnings Growth Ratio

    USANA Health Sciences has a PEG Ratio of 0.87. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    USANA Health Sciences has a P/B Ratio of 0.98. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about USANA Health Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    6.16% of the float of USANA Health Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    USANA Health Sciences has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in USANA Health Sciences has recently decreased by 3.21%, indicating that investor sentiment is improving.
  • Dividend Yield

    USANA Health Sciences does not currently pay a dividend.

  • Dividend Growth

    USANA Health Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.16% of the float of USANA Health Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    USANA Health Sciences has a short interest ratio ("days to cover") of 5.1.
  • Change versus previous month

    Short interest in USANA Health Sciences has recently decreased by 3.21%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for USANA Health Sciences this week, compared to 4 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, USANA Health Sciences insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $137,152.00 in company stock.

  • Percentage Held by Insiders

    Only 0.63% of the stock of USANA Health Sciences is held by insiders.

  • Percentage Held by Institutions

    54.25% of the stock of USANA Health Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about USANA Health Sciences' insider trading history.
Receive USNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

USNA Stock News Headlines

Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should buy in this market, this token might just be it.tc pixel
See More Headlines

USNA Stock Analysis - Frequently Asked Questions

USANA Health Sciences' stock was trading at $35.89 at the start of the year. Since then, USNA shares have decreased by 23.6% and is now trading at $27.4120.

USANA Health Sciences, Inc. (NYSE:USNA) posted its quarterly earnings results on Tuesday, July, 22nd. The company reported $0.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.54 by $0.20. The company earned $235.85 million during the quarter, compared to the consensus estimate of $225.20 million. USANA Health Sciences had a net margin of 3.79% and a trailing twelve-month return on equity of 9.48%.
Read the conference call transcript
.

Shares of USNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that USANA Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Home Depot (HD) and Netflix (NFLX).

Company Calendar

Last Earnings
7/22/2025
Today
10/02/2025
Next Earnings (Estimated)
10/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Personal Products
Current Symbol
NYSE:USNA
CIK
896264
Employees
1,700
Year Founded
1992

Price Target and Rating

High Price Target
$36.00
Low Price Target
$36.00
Potential Upside/Downside
+31.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.80
Trailing P/E Ratio
15.23
Forward P/E Ratio
11.19
P/E Growth
0.87
Net Income
$42.03 million
Net Margins
3.79%
Pretax Margin
7.18%
Return on Equity
9.48%
Return on Assets
6.95%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.15
Quick Ratio
1.47

Sales & Book Value

Annual Sales
$854.50 million
Price / Sales
0.59
Cash Flow
$3.80 per share
Price / Cash Flow
7.22
Book Value
$27.92 per share
Price / Book
0.98

Miscellaneous

Outstanding Shares
18,270,000
Free Float
18,157,000
Market Cap
$500.82 million
Optionable
Optionable
Beta
0.61

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NYSE:USNA) was last updated on 10/3/2025 by MarketBeat.com Staff
From Our Partners